[Prevention of pulmonary structural changes in experimental peritonitis].
D000818:Animals; D005260:Female; D007416:Intestinal Perforation / Q000150:complications; D008168:Lung / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000031:analogs & derivatives*; D008776:Methylprednisolone Hemisuccinate / Q000627:therapeutic use*; D010538:Peritonitis / Q000150:complications*; D051381:Rats; D011919:Rats, Inbred Strains; D012128:Respiratory Distress Syndrome / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D012459:Salicylates / Q000627:therapeutic use*
D012459:Salicylates; C025771:lysinsalicylate; D008776:Methylprednisolone Hemisuccinate; C029110:methylprednisolone 17-hemisuccinate; D008775:Methylprednisolone
Profilaxis de las alteraciones estructurales pulmonares en la peritonitis experimental.